Co-trimoxazole induced multi-organ failure

Canadian Journal of Hospital Pharmacy

Volumn 50, Issue 6, 1997, Pages 277-280

  Gerber, Patricia ^a   Brown, Glen ^b   Grant, Greg ^c  

^a BC CHILDREN S HOSPITAL   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c St Paul s Hospital

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COTRIMOXAZOLE; IBUPROFEN; LACTATE DEHYDROGENASE; PARACETAMOL; SULFONAMIDE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERSENSITIVITY REACTION; LABORATORY DIAGNOSIS; MULTIPLE ORGAN FAILURE; MYALGIA; RASH; REFERENCE VALUE; UREA NITROGEN BLOOD LEVEL; URINARY TRACT INFECTION;

EID: 0031426856     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Int Med 1986;105:179-84.
2. Rieder MJ, Shear NH, Kanee A, Tang BK, Spielberg SP. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991;49:13-7.
3. Dyvone CA, Chan CH, Zimmerman HJ. Sulfonamide hepatic injury: review of the literature and report of a case due to sulfamethoxazole. N Eng J Med 1967;277:785-8.
4. Pickert CB, Belsha CW, Kearns GL. Multi-organ disease secondary to sulfonamide toxicity. Pediatrics 1994; 94:237-9.
5. Rinkoff SS, Spring M. Toxic depression of the myeloid elements following therapy with the sulfonamides: report of 8 cases. Ann Int Med 1941;15:89-91.
6. Gupta A, Eggo MC, Uetrecht JP, Cribb AE, Daneman D, Rieder MJ, et al. Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides. Clin Pharmacol Ther 1992;51:156-66.
7. Blanchard AJ, Mertens GA. Hypersensitivity myocarditis occurring with sulfamethoxypyridine therapy. Can Med Assoc J 1958;79:627-30.
8. Guttendorf RJ, Wedlund PJ. Genetic aspects of drug disposition and therapeutics. J Clin Pharmacol 1992;32:107-17
9. Rowland M, Tozer TN. Clinical pharmacokinetics, concepts and applications. Second ed. Philadelphia: Lea & Febiger; 1989.
10. Lee, WM. Drug-induced hepatotoxicity. N Eng J Med 1995;333:1118-27.
11. Schiff L, ed. Diseases of the liver. Second ed. Philadelphia: Lippincott Company; 1963.
12. Antonovych TT. Drug-induced nephropathies. Pathol Annu 19:165-96, 1984.
13. Muehrcke RC, Volini FI, Morris AM, Moles JB, Lawrence AG. Acute toxic nephropathies: clinical pathologic correlations. Ann Clin Lab Sci 1976;6:477-513.
14. Kleinknecht D, Kanfer A, Morel-Maroger L, Mery J. Immunologically mediated drug-induced acute renal failure. Contr Nephrol 1978;10:42-52.
15. Walker DH, Barbour AG, Oliver JH, Lane RS, Dumler JS, Dennis DT, et al. Emerging bacterial zoonotic and vector-borne diseases. JAMA 1996;275:463-9.
16. Halperin JJ, Logigian EL, Finkel MF, Pearl RA. Practice parameters for the diagnosis of patients with the nervous system Lyme borrelosis (Lyme disease). Neurology 1996;46:619-27.
17. Spielberg SP. Acetaminophen toxicity in human lymphocytes in vitro. J Pharmacol Exp Ther 1980;213:395-8.
18. Anon. Co-trimoxazole use restricted. Drug Ther Bull 1995;33:92-3.
19. Turnidge JD. A reappraisal of co-trimoxazole. Med J Aust 1988;148:296-305.